India Antimalarial Drugs Market to be dominated by the Eastern India region through 2028.
Rising incidences of
malaria in India is expected to drive the growth of India Antimalarial Drugs
Market in the forecast period, 2024-2028.
According
to TechSci Research report, “India Antimalarial Drugs Market –Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028”, India Antimalarial Drugs Market is anticipated to grow at a steady rate in
the forecast period, 2024-2028. This can be attributed to the high prevalence
of malaria, rising healthcare expenditure and increasing R&D activities.
The antimalarial drugs market in India is driven by
several factors, including the increasing prevalence of malaria, a growing
demand for effective treatment options, and ongoing government initiatives
aimed at reducing the burden of the disease. Additionally, the availability of
a strong manufacturing base, and a favorable regulatory environment are also
contributing to the market's growth. However, the market is also facing several
challenges, including the emergence of drug-resistant strains of malaria, the
high cost of newer treatments, and a lack of access to healthcare in certain
regions.
The COVID-19 pandemic has had a significant impact
on the antimalarial drugs market in India. While the demand for antimalarial
drugs has remained steady, disruptions to supply chains and manufacturing have
led to shortages of certain medications. Additionally, efforts to control the
spread of COVID-19 have diverted resources and attention away from malaria
control efforts, leading to a potential increase in malaria cases. This shift
in focus has also affected clinical trials and research related to new
antimalarial treatments. However, the pandemic has also led to increased
awareness about the importance of public health measures and access to
healthcare, which may ultimately benefit the fight against malaria in the long
term.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "India Antimalarial Drugs Market"
India Antimalarial Drugs
Market can be segmented by
drug class, by mechanism of action, by distribution
channel and by region.
India Antimalarial Drugs
Market can be divided into Aryl aminoalcohol compounds, Antifolate compounds,
Artemisinin compounds, Others, based on drug class. Artemisinin compounds are
expected to dominate the antimalarial drugs market in India due to their proven
effectiveness against malaria and the increasing prevalence of drug-resistant
strains of the disease. These compounds are derived from the Artemisia annua
plant, which is native to China but is now being cultivated in India as well.
They have a high potency against malaria parasites and are able to rapidly
reduce the parasite load in patients, making them a crucial part of malaria
treatment regimens. Additionally, the Indian government has recently launched
initiatives to increase the production and availability of artemisinin-based
combination therapies (ACTs), which combine artemisinin with other drugs to
improve treatment outcomes. As a result, artemisinin compounds are expected to
acquire the largest share of the antimalarial drugs market in India in the
forecast period.
India Antimalarial Drugs
Market is divided into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, based
on distribution channel. Hospital pharmacies are expected to dominate the
antimalarial drugs market in India due to their role as a primary source of
healthcare for many patients. Hospitals are often equipped with the necessary
resources and personnel to manage complicated cases of malaria and provide
timely treatment. However, the rise of online pharmacies in India is expected
to disrupt this trend in the forecast period. Online pharmacies offer
convenience and accessibility to patients who may not have access to physical
pharmacies, particularly in remote or rural areas. Additionally, the COVID-19
pandemic has led to an increase in the use of online pharmacies as patients
seek to minimize their exposure to the virus. As a result, online pharmacies
are expected to acquire the largest share of the antimalarial drugs market in
India in the forecast period.
Major companies operating in India Antimalarial Drugs Market are:
- Cipla
Ltd
- Sun
Pharmaceutical Industries Ltd
- Glenmark
Pharmaceuticals Ltd
- Strides
Pharma Science Ltd
- Ipca
Laboratories Ltd
- Aurobindo
Pharma Ltd
- Alkem
Laboratories Ltd
- Novartis
India Ltd
- Lupin
Limited
- Cadila
Healthcare Ltd
Download Free Sample Report
Customers can also request
10% free customization in this report.
“The
antimalarial drugs market in India is expected to grow steadily in the coming
years, driven by factors such as the increasing prevalence of malaria, rising
healthcare expenditure, and ongoing government initiatives. Clinical trials and
research into new antimalarial drugs and therapies are also contributing to the
market's growth. Technological advancements, such as the development of rapid
diagnostic tests and the use of mobile health technologies to track and monitor
disease outbreaks, are also expected to play a role in improving malaria
control and treatment in India. However, challenges such as drug resistance and
access to healthcare in certain regions remain significant obstacles to
progress in this area. Continued investment in research and development, as
well as efforts to improve access to healthcare, will be critical to ensuring
continued growth and progress in the fight against malaria in India.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“India Antimalarial Drugs
Market By Drug Class (Aryl aminoalcohol compounds, Antifolate compounds,
Artemisinin compounds, Others), By Mechanism of Action (Treatment for Malaria,
Prevention from Malaria), By Distribution Channel (Hospital Pharmacy, Retail
Pharmacy, Online Pharmacy), Region, Competition, Forecast & Opportunities,
2018-2028F”, has evaluated the future growth potential of India
Antimalarial Drugs Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in India
Antimalarial Drugs Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com